Roche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products declined significantly even though the diagnostics base business and newer drugs maintained their …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Gold (XAU/USD) falls on US interest rate, CHF turns bullish – Central banks in focus [Video] - March 27, 2023
- USD/CHF traces downbeat options market signals below 0.9200 - March 27, 2023
- Geneva to spend CHF 1bn on greening buildings - March 27, 2023